Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia
- 28 February 2007
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 153 (2) , 335.e1-335.e8
- https://doi.org/10.1016/j.ahj.2006.10.031
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Safety and Efficacy of Long-Term Co-Administration of Fenofibrate and Ezetimibe in Patients With Mixed HyperlipidemiaJournal of the American College of Cardiology, 2006
- Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemiaEuropean Heart Journal, 2005
- Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)The American Journal of Cardiology, 2005
- A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemiaClinical Therapeutics, 2004
- Efficacy and Safety of Ezetimibe Coadministered With Simvastatin in Patients With Primary Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled TrialMayo Clinic Proceedings, 2004
- DyslipidaemiaThe Lancet, 2003
- Relationships Between Low-Density Lipoprotein Particle Size, Plasma Lipoproteins, and Progression of Coronary Artery DiseaseCirculation, 2003
- Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemiaJournal of the American College of Cardiology, 2002
- Fenofibrate Lowers Plasma Triglycerides and Increases LDL Particle Diameter in Subjects With Type 2 DiabetesDiabetes Care, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001